BSPK
Price
$0.24
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
Capitalization
2.68M
CHSYF
Price
$1.35
Change
-$0.17 (-11.18%)
Updated
Aug 1 closing price
Capitalization
4.12B
Interact to see
Advertisement

BSPK vs CHSYF

Header iconBSPK vs CHSYF Comparison
Open Charts BSPK vs CHSYFBanner chart's image
Bespoke Extracts
Price$0.24
Change-$0.00 (-0.00%)
Volume$6.19K
Capitalization2.68M
China Medical System Holdings
Price$1.35
Change-$0.17 (-11.18%)
Volume$1K
Capitalization4.12B
BSPK vs CHSYF Comparison Chart in %
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSPK vs. CHSYF commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSPK is a Hold and CHSYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (BSPK: $0.24 vs. CHSYF: $1.35)
Brand notoriety: BSPK and CHSYF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BSPK: 100% vs. CHSYF: 100%
Market capitalization -- BSPK: $2.68M vs. CHSYF: $4.12B
BSPK [@Pharmaceuticals: Generic] is valued at $2.68M. CHSYF’s [@Pharmaceuticals: Generic] market capitalization is $4.12B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSPK’s FA Score shows that 0 FA rating(s) are green whileCHSYF’s FA Score has 1 green FA rating(s).

  • BSPK’s FA Score: 0 green, 5 red.
  • CHSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHSYF is a better buy in the long-term than BSPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSPK’s TA Score shows that 2 TA indicator(s) are bullish while CHSYF’s TA Score has 2 bullish TA indicator(s).

  • BSPK’s TA Score: 2 bullish, 6 bearish.
  • CHSYF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, CHSYF is a better buy in the short-term than BSPK.

Price Growth

BSPK (@Pharmaceuticals: Generic) experienced а -24.95% price change this week, while CHSYF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.12B) has a higher market cap than BSPK($2.68M). BSPK YTD gains are higher at: 294.737 vs. CHSYF (45.052). CHSYF has higher annual earnings (EBITDA): 2.05B vs. BSPK (-767.07K). CHSYF has more cash in the bank: 5.97B vs. BSPK (1.36K). BSPK has less debt than CHSYF: BSPK (1.46M) vs CHSYF (748M). CHSYF has higher revenues than BSPK: CHSYF (7.86B) vs BSPK (1.23M).
BSPKCHSYFBSPK / CHSYF
Capitalization2.68M4.12B0%
EBITDA-767.07K2.05B-0%
Gain YTD294.73745.052654%
P/E RatioN/A14.09-
Revenue1.23M7.86B0%
Total Cash1.36K5.97B0%
Total Debt1.46M748M0%
FUNDAMENTALS RATINGS
BSPK vs CHSYF: Fundamental Ratings
BSPK
CHSYF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
10043
PRICE GROWTH RATING
1..100
3748
P/E GROWTH RATING
1..100
10073
SEASONALITY SCORE
1..100
5015

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHSYF's Valuation (13) in the null industry is significantly better than the same rating for BSPK (95). This means that CHSYF’s stock grew significantly faster than BSPK’s over the last 12 months.

CHSYF's Profit vs Risk Rating (88) in the null industry is in the same range as BSPK (100). This means that CHSYF’s stock grew similarly to BSPK’s over the last 12 months.

CHSYF's SMR Rating (43) in the null industry is somewhat better than the same rating for BSPK (100). This means that CHSYF’s stock grew somewhat faster than BSPK’s over the last 12 months.

BSPK's Price Growth Rating (37) in the null industry is in the same range as CHSYF (48). This means that BSPK’s stock grew similarly to CHSYF’s over the last 12 months.

CHSYF's P/E Growth Rating (73) in the null industry is in the same range as BSPK (100). This means that CHSYF’s stock grew similarly to BSPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSPKCHSYF
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
9%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
9%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
78%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRU78.390.09
+0.11%
TransUnion
ZIMV18.99N/A
N/A
ZimVie
BBUC35.80-0.75
-2.05%
Brookfield Business Corp
BIOX1.70-0.14
-7.61%
Bioceres Crop Solutions Corp
POAI9.53-1.46
-13.32%
Predictive Oncology Inc

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and AVCNF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and AVCNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
N/A
AVCNF - BSPK
9%
Poorly correlated
-8.31%
CHSYF - BSPK
9%
Poorly correlated
N/A
CAIHF - BSPK
4%
Poorly correlated
N/A
BOIRF - BSPK
4%
Poorly correlated
N/A
ARSUF - BSPK
2%
Poorly correlated
N/A
More

CHSYF and

Correlation & Price change

A.I.dvisor tells us that CHSYF and BSPK have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHSYF and BSPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
BSPK - CHSYF
9%
Poorly correlated
N/A
CANN - CHSYF
7%
Poorly correlated
-12.47%
CAIHF - CHSYF
0%
Poorly correlated
N/A
CASBF - CHSYF
0%
Poorly correlated
N/A
BUDZ - CHSYF
-0%
Poorly correlated
+5.44%
More